View of Would other oral hypoglycaemics persist as an adequate 1ST line add-on therapy to metformin in patients with type 2 diabetes mellitus? No, it’s time to refocus!

Return to Article Details Would other oral hypoglycaemics persist as an adequate 1ST line add-on therapy to metformin in patients with type 2 diabetes mellitus? No, it’s time to refocus! Download Download PDF